Issue navigation
Volume 28, Issue 3, March 2022
Leading Off
Development of Balanced Whole System Value Measures for Inflammatory Bowel Disease Care in the IBD Qorus Collaborative Using a Modified Delphi Process
Brant J Oliver and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 327–336, https://doi.org/10.1093/ibd/izab091
Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease
Giorgos Bamias and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 337–349, https://doi.org/10.1093/ibd/izab251
Clinical Research
Histological Inflammation in the Endoscopically Uninflamed Mucosa is Associated With Worse Outcomes in Limited Ulcerative Colitis
Catarina Geraldes de Frias Gomes and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 350–357, https://doi.org/10.1093/ibd/izab069
Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients
Kaustav P Shah and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 358–363, https://doi.org/10.1093/ibd/izab068
Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016
Siddharth Singh and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 364–372, https://doi.org/10.1093/ibd/izab074
Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
Stefanie Howaldt and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 373–384, https://doi.org/10.1093/ibd/izab073
Patients With Inflammatory Bowel Disease on Treatment Have Lower Rates of Celiac Disease
Motasem Alkhayyat and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 385–392, https://doi.org/10.1093/ibd/izab084
Randomized Controlled Trial of Cognitive-Behavioral and Mindfulness-Based Stress Reduction on the Quality of Life of Patients With Crohn Disease
Ganit Goren and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 393–408, https://doi.org/10.1093/ibd/izab083
The Importance of Monitoring the Postpartum Period in Moderate to Severe Crohn’s Disease
Audrey Bennett and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 409–414, https://doi.org/10.1093/ibd/izab104
Early-Life Exposure to Antibiotics and Risk for Crohn’s Disease: A Nationwide Danish Birth Cohort Study
Anders Mark-Christensen and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 415–422, https://doi.org/10.1093/ibd/izab085
Basic Science Research
The Selective 5-HT1A Agonist SR57746A Protects Intestinal Epithelial Cells and Enteric Glia Cells and Promotes Mucosal Recovery in Experimental Colitis
Jens Walldorf and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 423–433, https://doi.org/10.1093/ibd/izab191
Antitumor Necrosis Factor-like Ligand 1A Therapy Targets Tissue Inflammation and Fibrosis Pathways and Reduces Gut Pathobionts in Ulcerative Colitis
Mina Hassan-Zahraee and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 434–446, https://doi.org/10.1093/ibd/izab193
Germline Alterations in Patients With IBD-associated Colorectal Cancer
Giuseppe Biscaglia and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 447–454, https://doi.org/10.1093/ibd/izab195
Oral Delivery of Encapsulated All-Trans Retinoic Acid Ameliorates Disease in Rodent Models of Colitis
Ferdinando Nicoletti and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 455–465, https://doi.org/10.1093/ibd/izab204
Clinical Review
The Impact of Alcohol in Inflammatory Bowel Diseases
Bradley A White and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 466–473, https://doi.org/10.1093/ibd/izab089
Clinical Brief Reports
COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association
Andrea Costantino and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 474–478, https://doi.org/10.1093/ibd/izab172
Noninfectious Pulmonary Complications Associated With Anti-Integrin Therapy: A Case Report and Systematic Review of the Literature
David Dulaney and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 479–483, https://doi.org/10.1093/ibd/izab212
Invited Editorial
Disease Flares in the Postpartum Period: Vigilance Is Key
Ankita Tirath and Sunanda V Kane
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 484–485, https://doi.org/10.1093/ibd/izab108
Invited Commentary
Insight into Inflammatory Bowel Disease Pathogenesis: Is the Answer Blowing in the Wind?
Sari M Herman and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 486–491, https://doi.org/10.1093/ibd/izab183
Addressing COVID-19 Vaccine Hesitancy in Patients with IBD
Dania Hudhud and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages 492–493, https://doi.org/10.1093/ibd/izab241
Corrigendum
Corrigendum to: Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial
Stefanie Howaldt and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Page 494, https://doi.org/10.1093/ibd/izab224
Letters to the Editor
Jaundice in a Primary Sclerosing Cholangitis Patient: A New Cause in a New Era
Nik Arsyad Nik Muhamad Affendi and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages e29–e30, https://doi.org/10.1093/ibd/izab250
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient With Crohn’s Disease
Carmelo Sofia and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages e31–e32, https://doi.org/10.1093/ibd/izab255
Tracheobronchial Crohn’s Disease: Case Report and Systematic Review of the Literature
Rao G Raghava and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages e33–e35, https://doi.org/10.1093/ibd/izab258
Successful Treatment of Ulcerative Colitis, Rectovaginal Fistula, and Skin Erythema Nodule With Adalimumab
Cong Dai and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages e36–e37, https://doi.org/10.1093/ibd/izab260
Response to “Strongyloides stercoralis in Acute Severe Ulcerative Colitis—A Triggering Nuisance or an Opportunistic Bystander?”
Akira Hokama and Jiro Fujita
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Page e38, https://doi.org/10.1093/ibd/izab261
Reply to Response to “Strongyloides stercoralis in Acute Severe Ulcerative Colitis—A Triggering Nuisance or an Opportunistic Bystander?” by Hokama et al
Anurag Sachan and Anupam Kumar Singh
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Page e39, https://doi.org/10.1093/ibd/izab262
Spontaneous Perforation in Crohn’s Disease: A Report of Two Cases
Bingqing Yu and others
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages e40–e42, https://doi.org/10.1093/ibd/izab264
Refractory Immune Checkpoint Inhibitor-induced Colitis Improved by Fecal Microbiota Transplantation: A Case Report
Cong Dai and Wei-Xin Liu
Inflammatory Bowel Diseases, Volume 28, Issue 3, March 2022, Pages e43–e44, https://doi.org/10.1093/ibd/izab265
Advertisement
Advertisement